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Expression of Three Forms of Melanoma Growth
Stimulating Activity (MGSA)/gro in Human Retinal
Pigment Epithelial Cells
Glenn J. Jaffe,* Ann Richmond,] Linda Van Le,% Rebecca L. Shattuck,\
Qiu Chen Cheng,] Fulton Wong,*§ and Wendy Roberts*
Purpose. To characterize mRNA expression and protein production of the cytokine MGSA/
gro in human retinal pigment epithelial (RPE) cells and to determine whether expression of
MGSA/gro is modulated by serum and the cytokines interleukin 1/3 (IL-1/3), tumor necrosis
factora (TNFcv), or transforming growth factor /3 (TGF/3) mediators implicated in proliferative
vitreoretinopathy (PVR).
Methods. Reverse-transcription polymerase chain reaction was used to determine the steady-
state mRNA expression of three forms of MGSA/gro, a, /?, and y, by cultured human RPE
cells in the presence or absence of recombinant IL-1/3, TNFa, or TGF/3, or when serum-
starved cells were re-fed with medium containing serum. Immunocytochemistry was used to
characterize RPE cell-associated MGSA/gro protein, and immunoprecipitation of MGSA/gro
from cell-conditioned medium was used to demonstrate MGSA/gro secretion.
Results. MGSA/gro mRNA was expressed minimally under basal conditions. Expression for all
three forms of MGSA/gro mRNA was induced in a dose- and time-dependent manner after
exposure to IL-1/3, to a lesser extent after exposure to TNFa, but not after exposure to TGF/3.
Serum induced MGSA/gro a and y transcripts, but not /3 transcripts. Cell-associated MGSA/
gro was identified on RPE cells grown in the absence of cytokines, but MGSA/gro was not
secreted under these conditions. Exposure to IL-lj8 did not consistently cause increased cell-
associated MGSA/gro; however, IL-1/3 induced secretion of MGSA/gro in a time-dependent
manner.
Conclusion. MGSA/gro is produced by human RPE in response to mediators implicated in
PVR. Because MGSA/gro is a pleiotropic modulator of cell proliferation and inflammation, it
may contribute to the intraocular wound healing response that characterizes PVR. Invest
Ophthalmol Vis Sci 1993;34:2776-2785.
JVlelanoma growth stimulating activity/gro (MGSA/
gro), is a recently described cytokine that was origi-
nally identified as an autocrine growth factor for mela-
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noma cells.12 Subsequently, a gene termed gro (for
growth responsive) was identified in transformed
hamster cells, human fibroblasts, and human tumor
cells,3 and a role for gro as an early response gene in
cell growth and as a mediator of the IL-l/?-induced
inflammatory response was hypothesized.4 Sequence
analysis revealed that the MGSA gene and the gro
gene were one and the same.35 In addition to the gro
gene originally described (gro a), two additional gro
genes—gro /? and gro 7—have been described.6'7
These genes are identical to the recently described hu-
man homologues of the murine MIP-2 gene, MIP-2a
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and MIP-2/3, respectively.8 MGSA/gro /3 and 7 share
93% and 87% identity with MGSA/gro a at the nu-
cleotide level. The differences in nucleotide sequence
among these genes result in 11 amino acid substitu-
tions in gro /3 and 15 amino acid substitutions in gro 7.
The functional significance of these alterations re-
mains to be determined. MGSA/gro is a member of a
family of proteins denoted CXC, which describes the
arrangement of the first two cysteines. Other members
of the CXC family include IL-8,9 platelet factor 4,
platelet basic protein and its cleavage products /3-
thromboglobulin and connective tissue activating pro-
tein III,10 chicken-v-src-inducible proteins (9E3),1011
rat CINC,12 7-interferon inducible protein 10,13
mouse macrophage inflammatory protein 2,14 and the
KC gene product.
Proliferative vitreoretinopathy (PVR) is a disease
characterized by breakdown of the blood-retinal
barrier associated with an intraocular wound healing
response that leads to the formation of fibrocellular
scar tissue on the surface and undersurface of the ret-
ina. Cell-mediated contraction of this tissue causes
traction or rhegmatogenous retinal detachment. Key
cell types, including retinal pigment epithelial (RPE)
cells, macrophages, and retinal glial cells have been
associated with this wound healing response.1516 Cyto-
kines have been increasingly implicated in the patho-
genesis of PVR. For example, elevated levels of the
cytokines tumor necrosis factor (TNFa),17 transform-
ing growth factor /? (TGF-/?),18 and interleukin 119 have
been found in the vitreous of patients with PVR. In
rabbit eyes, PVR is induced when serum components
or TGF/3 in combination with fibronectin18 are in-
jected into the vitreous cavity.
To date, MGSA/gro has not been identified in ocu-
lar tissue. In nonocular tissues, MGSA/gro is a pleio-
tropic cytokine that can influence cellular activities rel-
evant to PVR such as cell proliferation and migration.
We hypothesized that the RPE cell, an important cell
in PVR, would express MGSA/gro under the influ-
ence of mediators that are found in increased quanti-
ties in the vitreous of patients with PVR. Here, we
characterize mRNA expression and protein produc-
tion of MGSA/gro in human RPE cells and determine
whether expression of MGSA/gro is modulated by the




Human cadaveric donor eyes were obtained from the
North Carolina Organ Donor and Eye Bank within 24
hours of death. Cells were harvested from these eyes as
previously described.20 Cells were grown in Eagle's
minimal essential medium (MEM) with 10% fetal bo-
vine serum (FBS) at 37°C in a humidified environment
containing 5% CO2. For experiments, second to fifth
passage cells were seeded at a density of 30,000 to
40,000 cells/ml in 24-well culture plates or in 35-mm
or 60-mm culture dishes and were grown to visual con-
fluence. Purity of RPE cell cultures was confirmed by
cytokeratin staining as previously described.21 Cells
used in these experiments formed a contact-inhibited
monolayer, exhibited polygonal morphology charac-
teristic of RPE cells, and were stained uniformly for
cytokeratins.
RNA Extraction
Cells were grown to visual confluence in 60-mm tissue
culture dishes in MEM with 10% FBS. For experi-
ments, cells were exposed to MEM + 10% FBS, alone
or in combination with varying dosages of recombi-
nant human IL-1/3, TGF0 (Collaborative Research,
Bedford, MA), TNFa (Amgen Biologicals, Thousand
Oaks, CA), or cycloheximide (1 ixg/m\, Sigma, St.
Louis, MO) at 37°C, 5% CO2 for varying time inter-
vals. At the end of the incubation period, cells were
rinsed twice with MEM, and total RNA was extracted
as previously described.22 RNA purity was determined
by measuring OD260/OD28o»
 a nd RNA quantity was es-
timated from OD260.
cDNA Synthesis
Total RNA was converted to cDNA using a modifica-
tion of a previously described technique.23 One micro-
gram of total RNA in 10 /xl of DEPC-treated water was
added to 10 n\ of reverse transcription mixture con-
sisting of 2 n\ of 10X PCR buffer (500 mM KC1, 100
mM Tris HCL pH 9, 15 mM MgCl, 0.01% [wt/vol]
gelatin), 4 ixl of 5 mM dNTP (Pharmacia LKB Biotech.
Inc, Piscataway, NJ), 1 pi of Maloney Murine Leuke-
mia virus reverse transcriptase (200 U//il; BRL, Gaith-
ersburg, MD), 1 nl of random hexamers (100 pmol/jil;
Pharmacia LKB Biotech, Inc.), 0.5 n\ of RNasin (40
000 units/ml; Promega, Madison, WI), and 1.5 /zl of
DEPC-treated water. This mixture was incubated for
45 minutes at 37°C and then for 5 minutes at 90°C.
cDNA was stored frozen at —70°C.
PCR Amplification
One microliter of cDNA mixture was added to a PCR
reaction mixture consisting of IX PCR buffer, 2.5
pmol dNTP, 5 pmol of MGSA/gro a, /?, or 7 or glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH)
primer pairs, 1.25 unit TAQ polymerase (Promega),
and distilled water in a total volume of 50 /il. The se-
quences of the MGSA/gro and GAPDH primer pairs
have been previously described.6-24 GAPDH primer
pairs were synthesized at the Nucleic Acid Synthesis
and Analysis Facility at Lineberger Cancer Center
(Chapel Hill, NC). The reaction mixture was overlaid
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with mineral oil and amplified in a PCR thermal cycler
(Perkin-Elmer/Cetus, Norwalk, CT) as follows: dena-
turation at 94°C for 1 minute, primer annealing at
55°C for 2 minutes, and extension at 72°C for 3 min-
utes. Only the inner wells of the PCR thermal cycler
were used to minimize variations in temperature
across the heating block. To verify that equivalent
quantities of mRNA in unknown samples were reverse
transcribed to cDNA, samples were also incubated
with GAPDH primer pairs as previously described.24
cDNA from adherent human macrophages was used as
positive control PCR template for MGSA/gro a, /?,
and y. PCR reaction mixtures without the addition of
cDNA template were used as negative controls. In
some experiments, positive control cDNA template
obtained from RPE cells stimulated with IL-1/3 was
serially diluted and amplified with corresponding spe-
cific primer pairs in parallel with unknown samples.
To be certain that the amount of cDNA in the stan-
dard dilution curve bracketed the amount in the un-
known samples, the standard dilution curve was pre-
pared beginning with 3 /x\ of cDNA in the PCR mix-
ture (1 fil of unknown sample cDNA was used in the
PCR mixture). All cDNA samples were amplified in
parallel with dilution series in the same PCR run to
eliminate run-to-run variation. Ten fA aliquots were
removed from the reaction mixture at different cycles
to insure that PCR products were evaluated during the
exponential phase of the amplification process. PCR
products from the unknown samples and dilution se-
ries were run on a 2% agarose gel (Ultrapure, BRL,
Gaithersburg, MD) with TBE (TBE: Tris 21 g/1, boric
acid 11 g/1, EDTA .002 M, pH = 8) running buffer.
Gels were stained with ethidium bromide and photo-
graphed with Polaroid film (type 55) (Polaroid, Cam-
bridge, MA).
The relative intensity of the bands was measured
using densitometric measurements obtained from the
photographic negatives with a high-resolution black-
and-white camera (Dage/MTI, Michigan City, IN)
coupled to an image processor (Imaging Technol-
ogy, Woburn, MA), driven by JAVA densitometric soft-
ware (Jandel Scientific, San Rafael, CA) as previously
described.25'26 Relative differences in mRNA expres-
sion among samples were determined by comparison
with the standard dilution curve as previously de-
scribed.27"30 Measurements obtained from the dilu-
tion series were fit to a regression line using Cricket
Graph software on a Macintosh computer (Cupertino,
CA). The relative concentration of mRNA was deter-
mined by comparison with the calculated regression
line.
Restriction Enzyme Analysis
Restriction enzyme analysis was performed to confirm
the identity of PCR products as previously de-
scribed.2731 MGSA/gro a, 0, and 7 PCR products have
unique restriction sites for HinD III, Msp I, and Hpa
I, respectively. Samples of MGSA/gro a, (3, and 7 PCR
products were digested with HinD III, Msp I, and Hpa
I (Promega), respectively. Restriction digests were run
on agarose gels, and bands were visualized with ethid-
ium bromide.
Immunocytochemistry
To examine the distribution of MGSA/gro in cultured
RPE, cells were seeded at 20 000 cells/ml in 8-well
plastic chamber slides (Lab Tek, Napier IL). Cells were
grown in MEM + 10% FBS. After 72 hours, cells were
washed twice with MEM, and medium was replaced
with fresh MEM + 0.2% lactalbumin hydrolysates (LH;
Sigma, St. Louis, MO), MEM + 1% FBS, or MEM +
10% FBS, in the presence or absence of IL-1/3 (5 U/
ml). After varying time periods, cells were fixed with
10.7% formalin/0.2% glutaraldehyde/0.6% Tris buff-
ered saline (pH = 7.5). Cells were stained for MGSA
using monoclonal antibody FB2AH7 (1:2 dilution of
supernatent fluid) and the Vectastain ABC kit (Vector-
Lab, Burlingame, CA) as previously described.5 For
controls, cells in parallel wells were processed identi-
cally except that a mouse monoclonal antibody (IgMJ
to granulocyte associated antigen (1:10 dilution;
DAKO-M1; Dakopatts a/s, Glostrup, Denmark) was
substituted for FB2AH7 (IgMJ. This antibody was
used at a 1:10 dilution to deliver an IgM concentration
equivalent to that of FB2AH7 at the 1:2 dilution.
Metabolic Labeling and Immunoprecipitation
of MGSA/gro Protein
Retinal pigment epithelial cells were seeded in 35-mm
culture dishes and grown to visual confluency in MEM
+ 10% FBS. Cells were rinsed twice with phosphate
buffered saline, once with cysteine and methionine-
free MEM (Lineberger Cancer Institute Tissue Cul-
ture Facility, Chapel Hill, NC) and incubated for 24
hours with 750 /x\ of cysteine and methionine-free
MEM and 35S-labeled cysteine and methionine (150
/iCi/ml; ICN) in the presence or absence of IL-1/3.
After incubation, PMSF was added to a final concen-
tration of 1 mM, and MGSA/protein was immunopre-
cipitated using a modification of a previously de-
scribed technique,32 as follows: Samples were pre-
treated with 10 ii\ of normal goat serum and a
suspension of 4 mg protein A-Sepharose in 40 fi\ of 20
mM HEPES pH = 7.4 at 4°C for 1 hour. The protein
A-Sepharose beads were removed by centrifugation,
and the pretreated samples were incubated overnight
at 4°C with MGSA/gro a antiserum raised in rabbits
to the KLH-coupled peptide C-PIVKKIIEKMLNSD-
KSN at a 1:200 dilution. The next day, samples were
incubated for 1 hour with a suspension of 4 mg pro-
tein A-Sepharose beads in 40 /xl of 20 mM HEPES (pH
= 7.4). The protein A-Sepharose beads were pelleted
and then washed four times in Tris-buffered RIPA (10
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mMTris,pH = 7.4, 1% Triton X-l 00,1 mMPMSF,30
mM pyrophosphate, 50 mM NaCl, 50 mM NaF, 0.1 M
Na3VO4, 10 /*g/ml aprotinin). The washed beads were
heated with 100 ju.1 of SDS gel electrophoresis loading
buffer at 100°C for 5 minutes. The beads were re-
moved by centrifugation, and the supernatent was
loaded on a 15% SDS-polyacrylamide gel.33
RESULTS
MGSA/gro mRNA Expression
Semiquantitative PCR was used to determine the rela-
tive amount of MGSA/gro mRNA expressed in the
presence or absence of IL-1/3 (5 U/ml for 4 hours),
TNFa (10 ng/ml for 4 hours), or TGF0 (10 ng/ml for
4 hours) in 10, 6, and 5 different human RPE cell
lines, respectively. Results from this type of analysis
are similar to those determined from Northern blot
analyses (Jaffe GJ, unpublished data, 1990). For each
cell line tested, transcripts for MGSA/gro either were
not detected or were expressed at low levels in the
absence of cytokines, but all three forms (MGSA/gro
IL-1/3
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FIGURE 2. PCR-cDNA gel showing the effect of varying ex-
posure periods to IL-1/? (5 U/ml) or TNFa (10 ng/ml) in a









FIGURE 1. PCR-cDNA gel showing the effect of varying con-
centrations of IL-1/? on the expression of MGSA/gro
mRNA in a representative cell line (cell line T-35), Cells were
exposed to IL-1/3 for 4 hours. PCR amplification for 35 cy-
cles.
a, (8, and 7) were induced after exposure to IL-1/3 and
TNFa. In contrast, TGF-/3 did not consistently induce
MGSA/gro expression. Induction of MGSA/gro tran-
scripts was dose- and time-dependent. Maximal induc-
tion occurred after exposure to 5 U/ml IL-1/3 (Fig. 1)
and 10 ng/ml TNFa (not shown). Induction occurred
rapidly; steady state transcripts were detected by 1
hour and were maximal 2 to 4 hours after cells were
exposed to recombinant cytokines. By 8 hours, steady
state mRNA expression had begun to decrease (Fig.
2). IL-1 /3 consistently induced higher levels of MGSA/
gro than TNFa (Table 1). To determine whether new
protein synthesis was important for cytokine-mediated
induction of MGSA/gro mRNA, cells were exposed to
IL-1/3 (5 U/ml) in the presence or absence of the pro-
tein translation inhibitor cycloheximide. Exposure of
cells to IL-1/3 in the presence of CHX resulted in su-
perinduction of MGSA/gro mRNA, compared to the
levels produced by exposure to IL-1/3 alone (Fig. 3).
Exposure to CHX alone (1 /xg/ml) produced moderate
induction of MGSA/gro.
When cells were grown continuously in serum
containing medium, only minimal levels of MGSA/gro
were expressed. However, when cells were serum-
starved and re-fed with medium containing 10% FBS,
there was a time-dependent induction of MGSA/gro a
and 7 similar to that observed after exposure to IL-1 /3
and TNF a; MGSA/gro a and 7 expression was first
detected at 1 hour, was maximal at 4 hours, and de-
clined thereafter (Fig. 4). In contrast, serum did not
induce MGSA/gro /3 expression.
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TABLE i. Amount of MGSA/gro mRNA
Induced by IL-1/3 Relative to TNFa*
Target mRNA
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* Values represent Llie ratio of the maximal amount of PCR
product detected in time-course experiments for IL-1 induction
to the maximal amount of PCR product measured in time-course
experiments forTNFo. The amount of PCR product was deter-
mined by comparison with a standard dilution curve, as described




In three RPE cell lines, the immunocytochemical
staining pattern of cell-associated MGSA/gro was eval-
uated in the presence or absence of IL-1 (3 and in con-
junction with measurement of MGSA/gro mRNA ex-
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FIGURE 3. PCR-cDNA gel showing the effect of cyclohexi-
mide (CHX) on MGSA/gro a, /?, and y mRNA expression in
a representative cell line (cell line T-61). Cells were exposed
for 4 hours to medium alone (lane 1), or medium containing
CHX (1 /tg/ml, lane 2), IL-1/3 (5 U/ml, lane 3), or IL-1/? (5
U/ml) + CHX (1 Mg/mO; (lane 4). Concentration of mRNA
in samples treated with CHX alone or IL-1/3 + CHX relative
to samples treated with IL-1/3 alone indicated below corre-
sponding lanes. Lanes from dilution curve correspond to
serial threefold dilutions of positive control template. Posi-
tive control template consisted of cDNA (1 fxg/m\) that was
reverse transcribed from RNA from human RPE stimulated
for 4 hours with IL-la (5 U/ml) + CHX (1 /tg/ml). The most
concentrated sample was obtained by using 3 til of positive
control template in the PCR reaction.
<•— 413
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FIGURE 4. PCR-cDNA gel showing the effect of serum on
MGSA/gro mRNA expression (cell line T-93). Cells exposed
to serum-free medium (MEM + 0.2% LH) for 24 hours, then
re-fed for indicated time periods with serum-containing me-
dium (MEM + 10% FBS). + = positive control. cDNA tem-
plate for positive control was obtained from reverse tran-
scription of total RNA extracted from human RPE stimu-
lated for four hours with IL-l/S (5 U/ml).
pression. MGSA/gro was detected immunocytochemi-
cally in all three cell lines (Table 2). The response to
IL-1/3 varied among the cell lines. In two lines, there
was no significant difference in the intensity of stain-
ing when cells were exposed to IL-1/? (5 U/ml; Figs. 5A
and B). In a third cell line, there was a time-dependent
increase in the intensity of staining up to a maximum
at 8 hours after cells were exposed to IL-1 /3 (5 U/ml;
Figs. 5C and D). The proportion of positively stained
cells also varied among cell lines. In two of three lines,
a higher percentage of cells was stained after exposure
to IL-1/3, whereas in a third line, there was no differ-
ence in the percentage of cells stained after exposure
to IL-1 (Table 2). In all cell lines, staining was distrib-
uted fairly evenly throughout the cytoplasm (Fig. 5).
Staining was observed among cells exposed to
MEM + 0.2% LH, MEM + 1% FBS, or MEM + 10%
FBS. The staining pattern (percentage of positively
stained cells and distribution of stain within individual
cells) was similar for cells grown in each of these me-
dia; however, the overall intensity of the staining was
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TABLE 2. Relative Staining Intensity and Percentage of Positively Stained Cells for Three



















*Craded on a 0 to +++ scale. 0 = no staining; + = slight staining; ++ = moderate staining; +++ = intense staining.
t Number expressed as percentage of positively stained cells out of total of 300 cells counted.
greatest for cells in MEM + 10% FBS and least for cells
in MEM + 0.2% LH.
In contrast to the pattern observed when cells
were stained using a primary antibody specific for
MGSA/gro, controls with an antibody to granulocyte-
associated antigen showed minimal staining. With con-
trol antibody, staining was nondetectable in two of
three cell lines under all conditions tested (Figs. 5E
and F). In the third cell line, there was light diffuse
staining of cells exposed to IL-1/3 for 8 hours that was
much less intense than that observed in cells stained
with MGSA/gro-specific antibody. In this cell line,
staining was undetectable for all other time points with
control antibody.
MGSA/gro Secretion
To determine whether RPE cells secrete MGSA/gro
protein, MGSA/gro a protein was immunoprecipi-
tated from RPE-conditioned medium obtained from
three separate cell lines. MGSA/gro a was not de-
tected in conditioned medium from any of the cell
lines when cells were grown in medium alone. In con-
trast, when cells were exposed to medium containing
IL-1/3, all three cell lines secreted MGSA/gro a that
was readily detected by immunoprecipitation (Fig. 6).
The time course of MGSA/gro secretion was exam-
ined in one cell line. MGSA/gro was first detected in
RPE-conditioned medium by 4 hours and increased
thereafter during the collection period (Fig. 7).
DISCUSSION
We have shown that in RPE cells, MGSA/gro mRNA is
minimally expressed under basal conditions. In con-
trast, mRNA expression is induced for all three forms
—MGSA/gro a, ft, and y—after cells are exposed to
the inflammatory cytokines IL-1/3 and TNFa, and
mRNA for gro a and y is induced after serum-starved
cells are re-fed serum. The pattern of mRNA expres-
sion for each of the specific forms of MGSA/gro is
cell-type specific. Like RPE cells, human umbilical
vein endothelial cells, human foreskin fibroblasts, and
mammary epithelium do not express MGSA/gro
under basal conditions, but all three forms are in-
duced after exposure to IL-1 or TNFa.4>6>34-35 In con-
trast, adherent macrophages express MGSA/gro a, ft,
and 7 constitutively, whereas polymorphonuclear leu-
kocytes and lymphocytes only express MGSA/gro a
constitutively. The significance of these varying ex-
pression patterns is unclear. Differential regulation of
MGSA/gro mRNA among different cell-types suggests
possible functional differences in the translated pro-
teins. Although differences in protein structure and
function have been predicted on the basis of differ-
ences in the amino acid sequences coded by MGSA/
gro a, ft, and 7 mRNA,6 little is actually known regard-
ing the full range of biologic activities of each of these
peptides.
Cycloheximide alone induced MGSA/gro mRNA
and caused superinduction of IL-1 mediated expres-
sion. Superinduction of MGSA/gro also has been ob-
served for other cell types.4'519 Similarly, we have ob-
served CHX-mediated superinduction of macrophage
colony stimulating factor27 and IL-128 in human RPE.
These results indicate that new protein synthesis is not
required for MGSA/gro expression. Furthermore, as
previously suggested, expression may be regulated
post-transcriptionally by a repressor protein that rec-
ognizes AU-rich sequences that mediate rapid cyto-
kine mRNA degradation.3-5
The mechanism by which cytokines and serum ac-
tivate MGSA/gro mRNA in RPE cells remains to be
determined. Steady state mRNA levels can be in-
creased by transcriptional activation or by stabilization
of MGSA/gro mRNA. Our study design did not allow
us to distinguish between these two mechanisms. How-
ever, in fibroblasts, IL-1 and TNFa transcriptionally
activate all three forms of MGSA/gro via the cytokine
response element NF-kB. This cytokine-mediated re-
sponse differs from the growth-mediated activation of
transcription induced by serum.36 In fibroblasts,
MGSA/gro a, ft, and 7 mRNA also are stabilized by
IL-1, thereby prolonging their respective half-lives.34
We propose that in RPE, expression of MGSA/gro
may be similarly regulated transcriptionally and post-
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FIGURE 5. Iminunocytochemical staining of two representative RPE cell lines for MGSA/gro.
Cells were exposed to medium alone {MEM + 10% FBS; A, C, E), or to medium containing
IAB-1/3 (U/rnl) for 8 hours (B, D, F), then stained with the MGSA/gro primary antibody
FB2AH7 (A, B, C, D) or with a nonspecific antibody (B, E). (A, B) From cell line T-76. (C, D,
E, F) From cell line T-77.
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FIGURE 6. Autoradiogram of MGSA/gro a protein immuno-
precipitated from RPE-conditioned medium. Samples from
cells in duplicate culture dishes incubated for 24 hours in
the presence or absence of IL-l/J (5 U/ml) were obtained
from three different cell lines, T-91, T-85, and T-35, as indi-
cated by numbers above lanes—1 to 3, respectively. S =
samples from cells stimulated with IL-1/3 (5 U/ml). U = sam-
ples from unstimulated cells.
transcriptionally by serum, IL-1, and TNFce. Experi-
ments are currently under way to test this hypothesis.
MGSA/gro protein secretion paralleled mRNA
expression; MGSA/gro was secreted only after cells
were exposed to IL-1/3. In contrast, cell-associated
MGSA/gro was detected by immunocytochemistry, in
the absence of cytokines, in all cell lines examined, but
the response to IL-1 was variable; only one of three
cell lines consistently showed a time-dependent in-
crease in cell-associated MGSA after exposure to IL-
1/?. In the remaining two cell lines, it is possible that
our immunocytochemical technique was not sensitive
enough to detect small IL-l/3-induced increases in
cell-associated MGSA/gro. Alternatively, it is possible
that in these cell lines, IL-1/? stimulated MGSA/secre-
tion at a rate that was approximately equivalent to new
protein synthesis, resulting in no net accumulation of
cell-associated MGSA/gro. The proportion of cells
staining for MGSA/gro in uninduced and IL-1/3-
induced cultures also differed among cell lines, sug-
gesting possible cell cycle variations. In any case, it is
likely that the differences observed among cell lines
reflect inherent biologic variability among donors. Pre-
viously, we have observed similar donor variability in
RPE protein synthesis for the cytokines IL-1 a and
macrophage colony stimulating factor.2728
The RPE cell, thought to be a key cell type in-
volved in PVR, is a potential source for a wide variety
of cytokines. In vitro, RPE cells constitutively produce
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basic fibroblast growth factor, transforming growth
factor-/?,18 insulin-like growth factor, macrophage col-
ony stimulating factor,27 monocyte chemoattractant
and activating factor (MCAF),38 and a platelet-derived
growth factor-like activity.37 Other cytokines, includ-
ing interleukin la and 1/3,28 interleukin 8,38 and, as
shown in the current report, MGSA/gro, are not ex-
pressed basally but are produced rapidly in response
to exogenous inflammatory peptides such as IL-1 and
TNFa. Because TNFex and IL-1 are present in elevated
quantities in the vitreous from patients with PVR,1719
and IL-1 activity is present in subretinal fluid from
patients with retinal detachment,40 these cytokines
may serve as potential stimuli for induction of IL-1,
IL-8, and MGSA/gro during the evolution of PVR.
Although increased quantities of TGF-/3 have been
found in the vitreous of patients with PVR, we did not
consistently observe induction of MGSA/gro mRNA
in response to TGF0. In PVR, it is likely that TGF-0
influences aspects of the wound healing response that
may be unrelated to modulation of MGSA/gro expres-
sion. PVR is associated with breakdown of the blood-
retinal barrier.15 We found that serum stimulated
MGSA/gro mRNA expression in RPE cells. Thus, in
PVR, serum components that leak into the vitreous
could act alone or in concert with cytokines like IL-1/3
andTNFa to induce expression of MGSA/gro in RPE.
Interleukin 8, MGSA/gro, and MCAF are
members of a rapidly emerging group of small pep-
tides that have been recently termed the "chemokine"
family.41 IL-8 and MGSA/gro are particularly closely
related; genes encoding these proteins are located on
chromosome 4.42 Both proteins competitively bind to
the neutrophil IL-8 receptor41 and mediate several
functions of polymorphonucleocytes.4344 Addition-
ally, both cytokines influence the activities of mono-
cytes,44 an important cell type implicated in PVR and
certain types of uveitis. In the current report, we have
Ohr 2 hr 4 hr 8 hr 24 hr
6.2 Kd
FIGURE 7. Autoradiogram of MGSA/gro a protein immuno-
precipitated from RPE-conditioned medium. Samples from
cells in duplicate culture dishes {cell line T-85) were incu-
bated for varying time periods in the presence or absence of
IL-1/3. S = samples from cells stimulated with IL-1/3 (5 U/ml)
for varying time periods (hours) as indicated above lanes. U
= samples collected from cells grown in IL-ljS-free medium
for 24 hours.
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demonstrated that MGSA/gro is produced by RPE
cells in response to IL-1/3 and TNFa with a time course
similar to that observed for IL-8. It is not immediately
evident why two closely related cytokines would be
produced by RPE cells under similar conditions and
would then antagonize one another's activity at the
receptor level. However, the complete range of fac-
tors that mediate transcription, translation, and secre-
tion of these peptides has yet to be determined; de-
pending on the situation, one may be produced prefer-
entially. Furthermore, the MGSA receptor appears to
have different physicochemical properties than the
IL-8 receptor,45 and activation of the receptor may
initiate different second messengers than those trans-
duced by the IL-8 receptor. Although some of the bio-
logic activities elicited by MGSA/gro and IL-8 overlap,
their full spectra of bioactivities are far from under-
stood and may differ significantly. Recently, purified
recombinant human MGSA/gro a and y have been
obtained from mammalian and insect expression sys-
tems, respectively,32-46 and recombinant IL-8 is now
commercially available. With the availability of rela-
tively large quantities of purified protein, it will be
possible to begin to clarify the role of these agents in
ocular disease.
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